Promising oncolytic agents for metastatic breast cancer treatment

New therapies for metastatic breast cancer patients are urgently needed. The long-term survival rates remain unacceptably low for patients with recurrent disease or disseminated metastases. In addition, existing therapies often cause a variety of debilitating side effects that severely impact qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cody, James J, Hurst, Douglas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918380/
https://www.ncbi.nlm.nih.gov/pubmed/27512671
http://dx.doi.org/10.2147/OV.S63045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918380/
https://www.ncbi.nlm.nih.gov/pubmed/27512671
http://dx.doi.org/10.2147/OV.S63045

Ejemplares similares